We are live on
!
Find out more
EAM
Exane Asset Management Portfolio holdings
AUM
$277M
1-Year Est. Return
26.27%
This Fund
S&P 500
This Quarter
Est. Return
+6.02%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$323M
AUM Growth
+$18.9M
(+6.2%)
Cap. Flow
+$8.2M
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
65.35%
Holding
46
New
11
Increased
18
Reduced
7
Closed
9
Top Buys
| 1 |
Wells Fargo
WFC
|
+$15.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$13.4M |
| 3 |
Citigroup
C
|
+$12.9M |
| 4 |
Westlake Corp
WLK
|
+$11.9M |
| 5 |
UBS Group
UBS
|
+$10.6M |
Top Sells
| 1 |
CNH
CNH Industrial
CNH
|
+$27.2M |
| 2 |
Philip Morris
PM
|
+$20.4M |
| 3 |
Bank of America
BAC
|
+$18.3M |
| 4 |
Criteo
CRTO
|
+$13.9M |
| 5 |
Merck
MRK
|
+$11.4M |
Sector Composition
| 1 | Materials | 28.15% |
| 2 | Healthcare | 26.06% |
| 3 | Financials | 17.72% |
| 4 | Communication Services | 10.63% |
| 5 | Energy | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Halliburton
HAL
$29.3B
| $2.1M | 0.65% |
42,580
-17,217
| -29% | -$926K |
|
27
Zimmer Biomet
ZBH
$17.6B
| $1.86M | 0.58% |
15,656
-46,142
| -75% | -$5.23M |
|
|
AAV
28
DELISTED
Advantage Oil & Gas Ltd
AAV
| $1.84M | 0.57% |
278,336
+141,036
| +103% | +$888K |
|
29
Deutsche Bank
DB
$67.2B
| $1.55M | 0.48% |
+102,430
| New | +$1.77M |
|
30
Illumina
ILMN
$28.1B
| $1.45M | 0.45% |
+8,738
| New | +$1.38M |
|
|
SLCA
31
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.27M | 0.39% |
26,491
+12,425
| +88% | +$665K |
|
32
Charter Communications
CHTR
$16.3B
| $1.23M | 0.38% |
3,769
-5,643
| -60% | -$1.8M |
|
33
Suncor Energy
SU
$73.2B
| $960K | 0.3% |
31,300
-4,564
| -13% | -$144K |
|
34
Telefônica Brasil
VIV
$22.2B
| $908K | 0.28% |
61,172
+16,853
| +38% | +$247K |
|
35
Ovintiv
OVV
$16.2B
| $746K | 0.23% |
+12,760
| New | +$765K |
|
|
VSM
36
DELISTED
Versum Materials, Inc.
VSM
| $345K | 0.11% |
11,264
| – | – |
|
|
CEB
37
DELISTED
CEB Inc.
CEB
| $157 | ﹤0.01% |
+2
| New | +$154 |
|
|
38
Bank of America
BAC
$427B
| – | – |
-829,776
| Closed | -$18.3M |
|
39
BioMarin Pharmaceuticals
BMRN
$11.5B
| – | – |
-101,548
| Closed | -$8.41M |
|
|
40
Criteo
CRTO
$1.12B
| – | – |
-338,969
| Closed | -$13.9M |
|
|
41
Merck
MRK
$315B
| – | – |
-202,698
| Closed | -$11.4M |
|
42
Occidental Petroleum
OXY
$54.3B
| – | – |
-30,181
| Closed | -$2.15M |
|
|
43
Philip Morris
PM
$299B
| – | – |
-223,323
| Closed | -$20.4M |
|
44
Stellantis
STLA
$16.8B
| – | – |
-75,871
| Closed | -$643K |
|
|
CNH
45
CNH Industrial
CNH
$13.2B
| – | – |
-3,854,920
| Closed | -$27.2M |
|
|
QGENF
46
DELISTED
QIAGEN NV
QGENF
| – | – |
-286,810
| Closed | -$7.51M |
|
Similar funds
RCA
TAM
IIA
TAP
TLA
1NWS
RFA
EFP
Exane Asset Management's Q1 2017 Portfolio in Review
As of Q1 2017, Exane Asset Management held 46 positions worth $323M, up 6.2% from $304M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Exane Asset Management's Q1 2017 filing shows 11 new, 18 increased, 7 reduced and 9 closed positions. Its largest new stake was Wells Fargo: 280,970 shares worth $15.6M. The largest sale was CNH Industrial, an estimated $27.2M.
By sector, the portfolio is most concentrated in Materials at 28% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Exane Asset Management's largest Q1 2017 buy was Wells Fargo: 280,970 shares worth $15.6M.
- Exane Asset Management added most to Bristol-Myers Squibb in Q1 2017, an estimated $13.4M increase.
- Exane Asset Management's biggest Q1 2017 reduction was Shire pic, cutting an estimated $5.34M.
- Exane Asset Management fully exited CNH Industrial in Q1 2017, selling an estimated $27.2M.
- Exane Asset Management's ten largest holdings make up 65% of its $323M portfolio in Q1 2017.
- Exane Asset Management opened 11 new positions and closed 9 in Q1 2017.
- Exane Asset Management's portfolio value rose 6.2% quarter-over-quarter to $323M.
Based on Exane Asset Management's 13F filing for Q1 2017, filed 8 May 2017.